IniTium is the latin word for beginning, Initiation. IniXium was created in 2014 as a customer-centric contract research organization (CRO) providing crucial knowledge-based expertise in structural biology at the initial stages of drug discovery to the biotech and pharmaceutical industry worldwide. We understand the needs of the sector for productivity, speed, reliability, and profitability, and value high quality, fast and professional industry grade research services for the best interest of the customer. Our culture of excellence is one that is truly collaborative and sincerely altruistic. We are committed to serving you, totally dedicated to your project, and keep your programs in permanent stealth mode when it comes to confidentiality.
Co-founder and Chief Executive Officer with over 20 years of experience in academic and industrial settings. René has setup the X-ray crystallography lab at Boehringer Ingelheim Canada Ltd, and participated in numerous drug discovery projects on several therapeutic targets.
Co-founder and Chief Scientific Officer with over 25 years of experience in protein chemistry and crystallography. Prior to founding IniXium, James setup and managed the protein and antibody production facility at IRIC in Montreal. Before that he was a membrane protein scientist at EMBL and M-Phasys GmbH in Germany
